IAI SPECIAL EDITION: Cost of illness for COVID-19 inpatients in West Nusa Tenggara, Indonesia

Authors

  • Cyntiya Rahmawati Muhammadiyah University of Mataram, Mataram, West Nusa Tenggara, Indonesia
  • Baiq Nurbaety Muhammadiyah University of Mataram, Mataram, West Nusa Tenggara, Indonesia
  • Nurul Qiyaam Muhammadiyah University of Mataram, Mataram, West Nusa Tenggara, Indonesia
  • Sulton Dini Muhammadiyah University of Mataram, Mataram, West Nusa Tenggara, Indonesia
  • Laelatul Maftuhah Muhammadiyah University of Mataram, Mataram, West Nusa Tenggara, Indonesia

DOI:

https://doi.org/10.46542/pe.2022.222.6669

Keywords:

Cost of illness, COVID-19 , Hospital, Indonesia, West Nusa Tenggara

Abstract

Background: COVID-19 is still a pandemic worldwide, including in Indonesia. The high number of COVID-19 cases, especially in West Nusa Tenggara (NTB), has a financial impact, considering that inpatient costs are borne by the government.

Objective: To calculate the cost of illness for COVID-19 inpatients at the NTB Provincial hospital.

Method: The method used was the cost of illness from a payer’s perspective. The population consisted of 822 patients.   

Results: The total direct medical cost of COVID-19 patients at the NTB Provincial hospital in 2020 was IDR 45,589,962,670, with an average of IDR 55,462,242. The average cost of COVID-19 inpatients without comorbidities was IDR 45,545,441 and IDR 71,926,056 for those with comorbidities.

Conclusion: The total cost of illness of COVID-19 in West Nusa Tenggara, Indonesia, was high. Therefore, preventive efforts are needed to reduce the incidence of COVID-19 in Indonesia, especially in West Nusa Tenggara.

Author Biographies

Cyntiya Rahmawati, Muhammadiyah University of Mataram, Mataram, West Nusa Tenggara, Indonesia

Department of Pharmacy

Baiq Nurbaety, Muhammadiyah University of Mataram, Mataram, West Nusa Tenggara, Indonesia

Department of Pharmacy

Nurul Qiyaam, Muhammadiyah University of Mataram, Mataram, West Nusa Tenggara, Indonesia

Department of Pharmacy

Sulton Dini, Muhammadiyah University of Mataram, Mataram, West Nusa Tenggara, Indonesia

Department of Pharmacy

Laelatul Maftuhah, Muhammadiyah University of Mataram, Mataram, West Nusa Tenggara, Indonesia

Department of Pharmacy

References

Bain, S.C., Czernichow, S., Bøgelund, M., Madsen, M.E., Yssing, C., McMillan, A.C., Hvid, C., Hettiarachchige, N., & Panton, U.H. (2021). Costs of COVID-19 pandemic associated with diabetes in Europe: a health care cost model. Current Medical Research and Opinion Volume 37(1), 27-36. https://doi.org/10.1080/03007995.2020.1862775

CDC. (2021, August 20). People with Certain Medical Conditions. Available at: https://www.cdc.gov/coronavirus/2019-ncov/need-extra-precautions/people-with-medical-conditions.html

Cutler, D.M., & Summers, L.H. (2020). The COVID-19 Pandemic and the $16 Trillion Virus. Journal of the American Medical Association, 324(15), 1495–1496. https://doi.org/10.1001/jama.2020.19759

Dinas Kesehatan NTB. (2021, August 22). Data COVID-19 NTB. Available at: https://corona.ntbprov.go.id/

Guan, W.J., Ni, Z.Y., Hu, Y., Liang, W.H., Ou, C.Q., He, J.X., Liu, L., Shan, H., Lei, C.L., Hui, D., Du, B., Li, L.J., Zeng, G., Yuen, K.Y., Chen, R.C., Tang, C.L., Wang, T., Chen, P.Y., Xiang, J., Li, S.Y., Wang, J.L., Liang, Z.J., Peng, Y.X., Wei, L., Liu, Y., Hu, Y., Peng, P., Wang, J., Liu, J., Chen, Z., Li, G., Zheng, Z., Qiu, S., Luo, J., Ye, C., Zhu, S. (2020). Clinical Characteristics of Coronavirus Disease 2019 in China. The New England journal of medicine, 382(18), 1708–1720. https://doi.org/10.1056/NEJMoa2002032

Hogan, A.B., Jewell, B.L., Sherrard-Smith, E., Vesga, J.F., Watson, O.J., Whittaker, C., Hamlet, A., Smith, J.A., Winskill, P., Verity, R., Baguelin, M., Lees, J.A., Whittles, L.K., Ainslie, K., Bhatt, S., Boonyasiri, A., Brazeau, N.F., Cattarino, L., Cooper, L.V., Coupland, H., Cuomo-Dannenburg, G., Dighe, A., Djaafara, B.A., Donnelly, C.A., Eaton, J.W., Elsland, S.L.V., FitzJohn, R.G., Fu, H., Gaythorpe, K.A.M., Green, W., Haw, D.J., Hayes, S., Hinsley, W., Imai, N., Laydon, D.J., Mangal, T.D., Mellan, T.A., Mishra, S., Nedjati-Gilani, G., Parag, K.V., Thompson, H.A., Unwin, H.J.T., Vollmer, M.A.C., Walters, C.E., Wang, H., Wang, Y., Xi, X., Ferguson, N.M., Okell, L.C., Churcher, T.S., Arinaminpathy, N., Ghani, A.C., Walker, P.G.T., Hallett, T.B. (2020). Potential impact of the COVID-19 pandemic on HIV, tuberculosis, and malaria in low-income and middle-income countries: a modelling study. The Lancet. Global health, 8(9), e1132–e1141. https://doi.org/10.1016/S2214-109X(20)30288-6

Maltezou, H.C., Giannouchos, T.V., Pavli, A., Tsonou, P., Dedoukou, X., Tseroni, M., Papadima, K., Hatzigeorgiou, D., Sipsas, N. V., & Souliotis, K. (2021). Costs associated with COVID-19 in healthcare personnel in Greece: a cost-of-illness analysis. The Journal of hospital infection, 114, 126–133. https://doi.org/10.1016/j.jhin.2021.04.018

Rascati, K. (2009). Essentials of Pharmacoeconomics. Philladelphia: Lippincott Williams & Wilkins

Sanyaolu, A., Okorie, C., Marinkovic, A., Patidar, R., Younis, K., Desai, P., Hosein, Z., Padda, I., Mangat, J., & Altaf, M. (2020). Comorbidity and its Impact on Patients with COVID-19. SN comprehensive clinical medicine, 1–8. Advance online publication. https://doi.org/10.1007/s42399-020-00363-4

Satuan Tugas Penanganan COVID-19. (2021, August). Peta Sebaran COVID-19. Available at: https://covid19.go.id/peta-sebaran-covid19

Singh, A.K., & Misra, A. (2020). Impact of COVID-19 and comorbidities on health and economics: Focus on developing countries and India. Diabetes & metabolic syndrome, 14(6), 1625–1630. https://doi.org/10.1016/j.dsx.2020.08.032

Singh, K., Kondal, D., Mohan, S., Jaganathan, S., Deepa, M., Venkateshmurthy, N.S., Jarhyan, P., Anjana, R.M., Narayan, K., Mohan, V., Tandon, N., Ali, M.K., Prabhakaran, D., & Eggleston, K. (2021). Health, psychosocial, and economic impacts of the COVID-19 pandemic on people with chronic conditions in India: a mixed methods study. BMC public health, 21(1), 685. https://doi.org/10.1186/s12889-021-10708-w

Tim Komunikasi Komite Penanganan COVID-19 dan Pemulihan Ekonomi Nasional. (2020). Vaksin, 3M, dan Hidup Sehat: Jurus Menyelesaikan Pandemi COVID-19. Available at: https://covid19.go.id/berita/vaksin-3m-dan-hidup-sehat-jurus-menyelesaikan-pandemi-covid-19

Walker, P., Whittaker, C., Watson, O.J., Baguelin, M., Winskill, P., Hamlet, A., Djafaara, B.A., Cucunubá, Z., Olivera Mesa, D., Green, W., Thompson, H., Nayagam, S., Ainslie, K., Bhatia, S., Bhatt, S., Boonyasiri, A., Boyd, O., Brazeau, N. F., Cattarino, L., Cuomo-Dannenburg, G., Dighe, A., Donnelly, C.A., Dorigatti, I., Elsland, S.L., FitzJohn, R., Fu, H., Gaythorpe, K.A.M., Geidelberg, L., Grassly, N., Haw, D., Hayes, S., Hinsley, W., Imai, N., Jorgensen, D., Knock, E., Laydon, D., Mishra, S., Nedjati-Gilani, G., Okell, L.C., Unwin, H.J., Verity, R., Vollmer, M., Walters1, C.E., Wang, H., Wang, Y., Xi, X., Lalloo, D.G., Ferguson1, N.M., Ghani, A. C. (2020). The impact of COVID-19 and strategies for mitigation and suppression in low- and middle-income countries. Science (New York, N.Y.), 369(6502), 413–422. https://doi.org/10.1126/science.abc0035

Wenham, C., Smith, J., Morgan, R., & Gender and COVID-19 Working Group (2020). COVID-19: the gendered impacts of the outbreak. Lancet (London, England), 395(10227), 846–848. https://doi.org/10.1016/S0140-6736(20)30526-2.

WHO. (2020, January 30). WHO Director-General's statement on IHR Emergency Committee on Novel Coronavirus (2019-nCoV). Available at: https://www.who.int/director-general/speeches/detail/who-director-general-s-statement-on-ihr-emergency-committee-on-novel-coronavirus-(2019-ncov)

Downloads

Published

2022-03-31

How to Cite

Rahmawati, C. ., Nurbaety, B. ., Qiyaam, N. ., Dini, S. ., & Maftuhah, L. . (2022). IAI SPECIAL EDITION: Cost of illness for COVID-19 inpatients in West Nusa Tenggara, Indonesia. Pharmacy Education, 22(2), p. 66–69. https://doi.org/10.46542/pe.2022.222.6669

Issue

Section

Special Edition